Sharma Mani’s Quiet Surge: AstraZeneca Insider Buys 20‑Share Deal Amid Flat Market, Hinting at Undervalued Future Upside
Insider buying shows AstraZeneca’s confidence: Sharma Mani’s recent purchases suggest the stock may rebound amid strong pipeline prospects.
3 minutes to read

